Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2020 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PSTX on Nasdaq
Shares outstanding
98,365,673
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$308,000 0
2025 Q1 100,000 $308,000 -$512,770,319 $3.08 1
2024 Q4 53,970,727 $518,071,150 +$17,008,819 $9.60 114
2024 Q3 53,512,171 $153,042,470 +$889,918 $2.86 96
2024 Q2 52,943,774 $154,557,545 -$128,087 $2.92 90
2024 Q1 52,747,602 $168,247,363 +$23,909,337 $3.19 90
2023 Q4 81,798 $274,841 +$143,704 $3.36 2
2023 Q3 45,200,925 $107,575,282 +$2,937,881 $2.38 84
2023 Q2 44,452,763 $78,219,937 -$5,620,803 $1.76 90
2023 Q1 44,133,147 $135,927,771 +$3,134,571 $3.08 99
2022 Q4 42,628,196 $225,912,311 +$18,394,772 $5.30 87
2022 Q3 38,557,620 $136,347,596 +$59,190,415 $3.53 63
2022 Q2 21,299,989 $54,953,750 -$1,876,363 $2.58 48
2022 Q1 24,168,854 $108,298,581 -$13,639,052 $4.48 60
2021 Q4 26,156,533 $178,123,275 -$953,279 $6.81 58
2021 Q3 26,116,811 $190,456,000 -$17,145,813 $7.29 66
2021 Q2 27,875,364 $279,303,000 -$10,695,849 $10.02 72
2021 Q1 28,924,836 $276,215,644 +$21,633,631 $9.55 60
2020 Q4 26,347,216 $288,434,000 +$15,181,992 $10.97 55
2020 Q3 24,542,173 $212,355,620 +$212,355,924 $8.87 50